Adma Biologics reported $17.67M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Adma Biologics ADMA:US $ 17.67M 1.88M
Agile Therapeutics AGRX:US $ 14.55M 1.94M
Alnylam Pharmaceuticals ALNY:US $ 154.47M 31.91M
Biocryst Pharmaceuticals BCRX:US $ 34.28M 1.1M
China Cord Blood CO:US 113.36M 11.92M
Dynavax Technologies DVAX:US $ 31.46M 2.66M
Minerva Neurosciences NERV:US $ 3.03M 398.63K
Novavax NVAX:US $ 95.99M 11.78M
Takeda 4502:JP 223.43B 7.65B